Oral Abstract Session 01 - Global HIV Vaccine Enterprise
Oral Abstract Session 01 - Global HIV Vaccine Enterprise
Oral Abstract Session 01 - Global HIV Vaccine Enterprise
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Topic 3: B Cell Immunology and Antibody Functions<br />
P03.53 LB<br />
Study on the Functional Role of Immunoglobulin E as<br />
Surrogate Marker for <strong>HIV</strong>/AIDS Infection<br />
B. Sonaimuthu 1 , V. Baghyanathan 1<br />
1King Institute of Preventive Medicine & Research, Chennai,<br />
India<br />
Background: IgE class of antibodies has been found in mammals<br />
and plays an important role in allergic and hypersensitivity<br />
reactions. Certain viral infections are known to produce specific<br />
IgE antibodies, to the extent that significant changes in the level<br />
of total serum IgE may occur. Study attempts to associate the<br />
Level of Ig E in <strong>HIV</strong> progression.<br />
Methods: The study involves fifty <strong>HIV</strong> seropositive patients<br />
attending Anti-Retroviral Therapy Centre, Department of<br />
Sexually Transmitted Disease, Rajaji Government Hospital, and<br />
Madurai,India subjected for the present study. The individual<br />
involves 27 <strong>HIV</strong>/ AIDS Male patients, 23 <strong>HIV</strong>/ AIDS Female<br />
patients. The control sample comprises 15 <strong>HIV</strong> sero negatives.<br />
The samples were collected at the informed consent of the<br />
patients. Serum sample were collected and IgE was quantified<br />
using MAGIWELL IgE quantitative solid phase Enzyme- linked<br />
Immunosorbent assay (ELISA).<br />
Results: The study documents highest percentage of deviation<br />
from the control observed in Male <strong>HIV</strong> seropositives (43.7%) and<br />
age-wise influence documents highest percentage of deviation in<br />
the age group 15- 29 years (56%).<br />
Conclusion: Serum IgE level in the present study found to be<br />
elevated from the normal range documents the existence of<br />
imbalance between Th 1 and Th 2 and associated with T-cell<br />
dysfunction and a hypergammaglobulinemia. The present results<br />
suggest that elevation of circulating IgE levels may be due, at least<br />
in part, to specific IgE directed to the <strong>HIV</strong> virus rather than as a<br />
result of a nonspecific phenomenon. <strong>HIV</strong> infected adults indicate<br />
that total IgE is also increased during the early stages of disease,<br />
and this elevation appears to be independent of CD4 counts<br />
and is not correlated with the levels of other immunoglobulins,<br />
suggesting an important role for IgE as a surrogate marker of<br />
disease progression Further research need to be exploited to<br />
bring out the exact role of IgE in <strong>HIV</strong> pathogenesis.<br />
P03.54 LB<br />
AIDS <strong>Vaccine</strong> 2<strong>01</strong>2<br />
Posters<br />
Pre-existing Humoral Immunity In Military Smallpox<br />
<strong>Vaccine</strong>es Temporally Effects MVA-Vectored<br />
Transgene Expression in Dendritic Cells<br />
V. Ngauy 1 , B. Slike 2 , M. Marovich 2<br />
1 Armed Forces Research Institute of Medical Sciences,<br />
Bangkok, Thailand; 2 US Military <strong>HIV</strong> Research Program, MD,<br />
USA<br />
Background: Modified Vaccinia Ankara (MVA), a vector-based<br />
vaccine that targets dendritic cells (DC) and induces cellmediated<br />
immunity, is a promising <strong>HIV</strong> vaccine candidate. As<br />
MVA vaccination strategies continue to be explored, concerns<br />
arise regarding transferability to individuals with pre-existing<br />
immunity to vaccina, particularly military personnel. Prior<br />
reports suggest long-lasting vaccinia immunity after childhood<br />
vaccination. This study, conducted in a unique cohort of adult<br />
primary vaccinees, explores how pre-exisiting humoral immunity<br />
to vaccinia affects entry and transgene expression of MVAvectored<br />
vaccines in a primary human DC infection model.<br />
Methods: Serum from military personnel vaccinated against<br />
smallpox with either Dryvax or ACAM2000 vaccines were<br />
obtained at 4 time points post-vaccination (n=50 per time point,<br />
400 total). As a comparator, n=25 individuals with longitudinal<br />
sera available at corresponding time points were studied to<br />
compensate for inter-individual variability in response over time.<br />
Sera were tested for inhibition of infection of DCs in vitro using<br />
either MVA-GFP or MVA-CMDR, an <strong>HIV</strong> vaccine candidate with<br />
env/gag/pol inserts, currently in clinical trials. Vaccinia naïve<br />
sera served as a negative control. Vaccinia binding titers were<br />
measured by ELISA.<br />
Results: Vaccinia binding antibody titers waned after 5 years and<br />
were undetectable 10 years after vaccination. Neutralizing activity,<br />
as measured by transgene expression in DCs, confirmed this finding.<br />
Expression and neutralization of <strong>HIV</strong> p24 (gag) expression data in<br />
DC were equivalent to that of GFP. No differences in neutralization<br />
activity were detected between Dryvax and ACAM2000 vaccinee<br />
sera at corresponding time points.<br />
Conclusion: In an adult, military, primary vaccinee population,<br />
humoral responses to smallpox vaccination do not persist as<br />
long as reported in the civilian population vaccinated during<br />
childhood. This data suggests that pox-vector based vaccines<br />
may be used in the military population, and that the age of<br />
primary vaccination influences durability of humoral immunity.<br />
143<br />
POSTERS